000			02019 a2200517 4500
005			20250513132450.0
264		0	_c19980102
008			199801s 0 0 eng d
022			_a0002-9440
040			_aNLM _beng _cNLM
100	1		_aPetit, A M
245	0	0	_aNeutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. _h[electronic resource]
260			_bThe American journal of pathology _cDec 1997
300			_a1523-30 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aEndothelial Growth Factors _xmetabolism
650	0	4	_aEpidermal Growth Factor _ximmunology
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aLymphokines _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aNeutralization Tests
650	0	4	_aReceptor, ErbB-2 _ximmunology
650	0	4	_aSignal Transduction _xphysiology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aRak, J
700	1		_aHung, M C
700	1		_aRockwell, P
700	1		_aGoldstein, N
700	1		_aFendly, B
700	1		_aKerbel, R S
773	0		_tThe American journal of pathology _gvol. 151 _gno. 6 _gp. 1523-30
999			_c9373338 _d9373338